Ultrasound-triggered release of materials entrapped in microbubble-liposome constructs: a tool for targeted drug delivery.

We investigated the preparation of ultrasound-triggered drug delivery system, based on a pendant complex of microbubble coated with liposomes. Biotinylated decafluorobutane microbubbles were coated with biotinylated liposomes via a streptavidin linker. Liposomes were prepared incorporating calcein and thrombin. Based on initial concentration of calcein, over 1 um(3) payload volume per each microbubble-liposome particle was achieved, when 100 nm liposomes were used. Insonation of microbubble-liposome pendants in vitro resulted in the complete destruction of microbubbles and triggered release of a significant fraction of the entrapped material. Treatment with 1MHz ultrasound (5 pulses, 100 ms, 7 MPa peak negative acoustic pressure) resulted in the release of ~30% of entrapped calcein, as estimated by the fluorescence quenching assay. Thrombin release from liposomes complexed with microbubbles (11% of entrapped material) due to ultrasound treatment was estimated by a chromogenic substrate study. Prior to insonation, substrate hydrolysis was at background level. Ultrasound-triggered release of thrombin from the pendant complexes caused an acceleration of blood clotting.

[1]  P. Marmottant,et al.  Controlled vesicle deformation and lysis by single oscillating bubbles , 2003, Nature.

[2]  D. Stewart,et al.  Therapeutic Arteriogenesis by Ultrasound-Mediated VEGF165 Plasmid Gene Delivery to Chronically Ischemic Skeletal Muscle , 2007, Circulation research.

[3]  Sanjiv Kaul,et al.  Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. , 2003, Ultrasound in medicine & biology.

[4]  V. Torchilin,et al.  Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. , 1991, Biochimica et biophysica acta.

[5]  Stefaan C De Smedt,et al.  Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  S. Libutti,et al.  Pulsed-High Intensity Focused Ultrasound and Low Temperature–Sensitive Liposomes for Enhanced Targeted Drug Delivery and Antitumor Effect , 2007, Clinical Cancer Research.

[7]  S. Ran,et al.  Increased exposure of anionic phospholipids on the surface of tumor blood vessels. , 2002, Cancer research.

[8]  E. Unger,et al.  DNA delivery to cells in vivo by ultrasound. , 2004, Methods in molecular biology.

[9]  Hairong Zheng,et al.  Dynamic microPET imaging of ultrasound contrast agents and lipid delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Y Wu,et al.  Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. , 1998, Investigative radiology.

[11]  K. Barišić,et al.  High efficiency entrapment of superoxide dismutase into mucoadhesive chitosan-coated liposomes. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[12]  Paul A. Dayton,et al.  Optical observation of contrast agent destruction , 2000 .

[13]  Nico de Jong,et al.  Ultrasound and Microbubble-Targeted Delivery of Macromolecules Is Regulated by Induction of Endocytosis and Pore Formation , 2009, Circulation research.

[14]  Ivan Spasojevic,et al.  Phase I Trial of Doxorubicin-Containing Low Temperature Sensitive Liposomes in Spontaneous Canine Tumors , 2006, Clinical Cancer Research.

[15]  F. Szoka,et al.  Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Acton,et al.  Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow. , 2006, Contrast media & molecular imaging.

[17]  K. Hynynen,et al.  Transcranial Magnetic Resonance Imaging– Guided Focused Ultrasound Surgery of Brain Tumors: Initial Findings in 3 Patients , 2010, Neurosurgery.

[18]  T. Marwick,et al.  What is the relationship between flow and function in diabetic cardiomyopathy? A quantitative study using contrast echo and strain rate imaging , 2004 .

[19]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[20]  Katherine W Ferrara,et al.  Therapeutic effects of paclitaxel-containing ultrasound contrast agents. , 2006, Ultrasound in medicine & biology.

[21]  Vladimir P Torchilin,et al.  Radio-frequency ablation increases intratumoral liposomal doxorubicin accumulation in a rat breast tumor model. , 2002, Radiology.

[22]  J. Fries,et al.  Specific occlusion of murine and human tumor vasculature by VCAM-1-targeted recombinant fusion proteins. , 2005, Journal of the National Cancer Institute.

[23]  Victor Frenkel,et al.  Delivery of systemic chemotherapeutic agent to tumors by using focused ultrasound: study in a murine model. , 2005, Radiology.

[24]  Zhong-gao Gao,et al.  Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. , 2007, Journal of the National Cancer Institute.

[25]  R. Vandenbroucke,et al.  Ultrasound exposure of lipoplex loaded microbubbles facilitates direct cytoplasmic entry of the lipoplexes. , 2009, Molecular pharmaceutics.